false0000949858BC0000949858dei:OtherAddressMember2024-06-052024-06-0500009498582024-06-052024-06-05

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 5, 2024

ACHIEVE LIFE SCIENCES, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware

033-80623

95-4343413

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

22722 29th Drive SE, Suite 100

Bothell, WA

 

98021

1040 West Georgia, Suite 1030

Vancouver, B.C., Canada

V6E 4H1

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (604) 210-2217

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of exchange on which registered

Common Stock, par value $0.001 per share

ACHV

The NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


 

Item 5.07 Submission of Matters to a Vote of Security Holders.

The Annual Meeting of Stockholders of Achieve Life Sciences, Inc. (the “Company”) was held on June 5, 2024. The following is a brief description of each matter voted upon and the certified voting results.

(1)
Election of eight directors to serve until the Company’s next annual meeting or until the directors’ successors are duly elected and qualified:

 

For

Withhold

Broker
Non-Votes

John Bencich

14,570,909

 

 

 

456,303

 

 

 

10,246,712

Stuart Duty

 

 

14,088,063

 

 

 

939,149

 

 

 

10,246,712

 

Vaughn Himes

 

 

14,600,768

 

 

 

426,444

 

 

 

10,246,712

 

Cindy Jacobs

 

 

14,498,319

 

 

 

528,893

 

 

 

10,246,712

 

Thomas B. King

14,095,642

 

 

 

931,570

 

 

 

10,246,712

Bridget Martell

14,159,031

 

 

 

868,181

 

 

 

10,246,712

Thomas Sellig

14,605,590

 

 

 

421,622

 

 

 

10,246,712

Richard Stewart

14,516,198

 

 

 

511,014

 

 

 

10,246,712

Pursuant to the foregoing votes, the nominees listed above were elected as directors to serve on the Company’s board of directors.

(2)
Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024:

 

For

Against

Abstain

Broker
Non-votes

24,825,016

 

 

 

 

230,631

 

 

218,277

 

 

 

 

Pursuant to the foregoing votes, the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 was ratified.

 

________________________

 

 

 

 

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

ACHIEVE LIFE SCIENCES, INC.

 

Date: June 6, 2024

 

/s/ John Bencich

 

John Bencich

Chief Executive Officer (Principal Executive and Financial Officer)

 

 


v3.24.1.1.u2
Document and Entity Information
Jun. 05, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 05, 2024
Entity Registrant Name ACHIEVE LIFE SCIENCES, INC.
Entity Central Index Key 0000949858
Entity Emerging Growth Company false
Entity File Number 033-80623
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 95-4343413
Entity Address, Address Line One 22722 29th Drive SE
Entity Address, Address Line Two Suite 100
Entity Address, City or Town Bothell
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98021
City Area Code 604
Local Phone Number 210-2217
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol ACHV
Security Exchange Name NASDAQ
Principal Address  
Document Information [Line Items]  
Entity Address, Address Line One 1040 West Georgia
Entity Address, Address Line Two Suite 1030
Entity Address, City or Town Vancouver
Entity Address, State or Province BC
Entity Address, Country CA
Entity Address, Postal Zip Code V6E 4H1

Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more Achieve Life Sciences Charts.
Achieve Life Sciences (NASDAQ:ACHV)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more Achieve Life Sciences Charts.